関節リウマチ患者で分子標的治療はMTXを比較して入 院を称する感染症を増加しない: レトロスペクティブコ ホート研究
Arthritis Res Ther. 2022 doi: 10.1186/s13075-022-02807-9
Retrospective, longitudinal, population-based study shows that despite an overall higher incidence of hospitalised infection (HI) in both elderly and older elderly patients compared to young patients, the risks of HI in patients exposed to targeted therapy versus MTX is not significantly increased.